ADELINE SADIPE: Open Payments
NPI 1942062757 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,055 in 213 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $5,891 · 2025 $5,055
Food & beverage: $5,055
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 21 | $712 |
| Vanda Pharmaceuticals Inc. | 20 | $686 |
| Neurocrine BioSciences, Inc. | 21 | $629 |
| Alkermes, Inc. | 21 | $484 |
| ABBVIE INC. | 29 | $416 |
| Otsuka America Pharmaceutical, Inc. | 21 | $409 |
| E.R. Squibb & Sons, L.L.C. | 9 | $295 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $293 |
| Teva Pharmaceuticals USA, Inc. | 16 | $261 |
| Lundbeck LLC | 9 | $181 |
Products named: HETLIOZ, INGREZZA, SPRAVATO, VRAYLAR, REXULTI, ARISTADA, COBENFY, CAPLYTA.
Industry payments across CA — which companies pay providers there.
